Cancer is the leading cause of death worldwide. Almost 50% of all cancer patients undergo radiation therapy (RT) during treatment, with varying success. The main goal of RT is to kill tumor cells by damaging their DNA irreversibly while sparing the surrounding normal tissue. The outcome of RT is often determined by how tumors recognize and repair their damaged DNA. A growing body of evidence suggests that tumors often show abnormal expression of DNA double-strand break (DSB) repair genes that are absent from normal cells. Defects in a specific DNA repair pathway make tumor cells overly dependent on alternative or backup pathways to repair their damaged DNA. These tumor cell-specific abnormalities in the DNA damage response (DDR) machinery can potentially be used as biomarkers for treatment outcomes or as targets for sensitization to ionizing radiation (IR). An improved understanding of genetic or epigenetic alterations in the DNA repair pathways specific to cancer cells has paved the way for new treatments that combine pharmacological exploitation of tumor-specific molecular vulnerabilities with IR. Inhibiting DNA repair pathways has the potential to greatly enhance the therapeutic ratio of RT. In this review, we will discuss DNA repair pathways in active cells and how these pathways are deregulated in tumors. We will also describe the impact of targeting cancer-specific aberrations in the DDR as a treatment strategy to improve the efficacy of RT. Finally, we will address the current roadblocks and future prospects of these approaches.
Keywords: DNA damage; DNA repair; Ionizing radiation (IR); cancer; charged particle therapy (CPT); radiotherapy; synthetic lethality.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Targeting DNA Double-Strand Break Repair Pathways to Improve Radiotherapy Response.Genes (Basel). 2019 Jan 4;10(1):25. doi: 10.3390/genes10010025. Genes (Basel). 2019. PMID: 30621219 Free PMC article. Review.
Targeting DNA damage response in cancer therapy.Cancer Sci. 2014 Apr;105(4):370-88. doi: 10.1111/cas.12366. Epub 2014 Mar 21. Cancer Sci. 2014. PMID: 24484288 Free PMC article. Review.
DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy.Front Oncol. 2013 May 10;3:113. doi: 10.3389/fonc.2013.00113. eCollection 2013. Front Oncol. 2013. PMID: 23675572 Free PMC article.
DNA Damage Response Proteins and Oxygen Modulate Prostaglandin E2 Growth Factor Release in Response to Low and High LET Ionizing Radiation.Front Oncol. 2015 Dec 7;5:260. doi: 10.3389/fonc.2015.00260. eCollection 2015. Front Oncol. 2015. PMID: 26697402 Free PMC article.
DNA double strand break repair inhibition as a cause of heat radiosensitization: re-evaluation considering backup pathways of NHEJ.Int J Hyperthermia. 2008 Feb;24(1):17-29. doi: 10.1080/02656730701784782. Int J Hyperthermia. 2008. PMID: 18214766 Review.
Cited by 2 articles
Molecular Signaling in Response to Charged Particle Exposures and its Importance in Particle Therapy.Int J Part Ther. 2018 Summer;5(1):60-73. doi: 10.14338/IJPT-18-00016.1. Epub 2018 Sep 21. Int J Part Ther. 2018. PMID: 31773020 Free PMC article. Review.
Cellular Stress Responses in Radiotherapy.Cells. 2019 Sep 18;8(9):1105. doi: 10.3390/cells8091105. Cells. 2019. PMID: 31540530 Free PMC article. Review.